piperacillin has been researched along with Sepsis in 131 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 26 (19.85) | 18.7374 |
| 1990's | 19 (14.50) | 18.2507 |
| 2000's | 18 (13.74) | 29.6817 |
| 2010's | 49 (37.40) | 24.3611 |
| 2020's | 19 (14.50) | 2.80 |
| Authors | Studies |
|---|---|
| Eb, F; Guillon, H; Mammeri, H | 1 |
| Bonomo, RA; Endimiani, A; Hujer, AM; Hujer, KM; Pulse, ME; Weiss, WJ | 1 |
| Besch, G; Capellier, G; Chaignat, C; Clairet, AL; Despres, C; Floury, SP; Labro, G; Lagoutte-Renosi, J; Montange, D; Piton, G; Puyraveau, M; Vettoretti, L; Vivet, B; Winiszewski, H | 1 |
| Al-Jebawi, Y; Karalic, K; Mhanna, MJ; Shekhawat, P | 1 |
| Annecke, T; Bach, F; Bauer, M; Bracht, H; Brenner, T; Brinkmann, A; Frey, O; Hagel, S; Hohn, A; Jarczak, D; Kiehntopf, M; Kluge, S; König, C; Lehmann, T; Michels, G; Müller, C; Neugebauer, S; Nierhaus, A; Pletz, MW; Roberts, JA; Weigand, M; Weismann, D; Witzke, D | 1 |
| Taito, S; Yoshihiro, S | 1 |
| Alrashed, MA; Borgstrom, MC; Kang, N; Perona, SJ; Torabi, MR | 1 |
| Hagel, S; Lehmann, T; Pletz, MW | 1 |
| Debaveye, Y; Dreesen, E; Gijsen, M; Spriet, I; Wauters, J | 1 |
| Braun-Feldweg, J; Germer, CT; Lock, JF; Meyer-Sautter, P; Rüsch, J; Surat, G | 1 |
| Akazawa, N; Itoh, N; Kuwahara, T; Yanaidani, T | 1 |
| Chai, MG; Cotta, MO; Farkas, A; Roberts, JA | 1 |
| Bauer, SR; Campbell, MJ; Dettmer, MR; Erickson, RM; Fertel, BS; Sacha, GL; Wesolek, JL | 1 |
| Babicky, ML; Behrman, SW; Bentrem, DJ; Bertens, KA; Brajcich, BC; Celinski, SA; Chan, CHF; Cohen, ME; D'Angelica, MI; Dillhoff, M; Dixon, MEB; Ellis, RJ; Fernandez-Del Castillo, C; Gholami, S; Gönen, M; House, MG; Karanicolas, PJ; Ko, CY; Lavu, H; Liu, JB; Maithel, SK; McAuliffe, JC; Ott, MJ; Pitt, HA; Reames, BN; Sanford, DE; Sarpel, U; Scaife, CL; Seo, SK; Serrano, PE; Smith, T; Snyder, RA; Talamonti, MS; Thompson, VM; Weber, SM; Yopp, AC; Zabor, EC | 1 |
| Colman, R; De Cock, PA; De Paepe, P; Devreese, M; Dhont, E; Hermans, E; Vande Walle, J; Verougstraete, N; Zeitlinger, M | 1 |
| Andereck, JW; Casey, JD; Dear, ML; Dennis, BM; Han, JH; Lloyd, BD; Marvi, TK; Nelson, GE; Qian, ET; Rice, TW; Seitz, KP; Self, WH; Semler, MW; Shotwell, MS; Siemann, JK; Siew, ED; Stollings, JL; Wang, L; Wrenn, JO; Wright, A; Wright, PW | 1 |
| AlAzmi, A; AlHashem, G; Jamal, W; Khodakhast, FB; Rotimi, VO; Sόki, J | 1 |
| Adams, R; Agus, A; Barnes, RA; Chau, I; Clarke, M; Coyle, V; Doran, A; Forde, C; Grayson, M; McAuley, DF; McDowell, C; McMullan, R; Plummer, R; Thomas, AL; Wilson, RH | 1 |
| Besset, S; Daufresne, P; Fillâtre, P; Flecher, E; Launey, Y; Le Tulzo, Y; Lemaitre, F; Maamar, A; Nesseler, N; Schmidt, M; Tadie, JM; Tattevin, P | 1 |
| Burdette, SD; Elliott, BP; Madden, JA; Markert, RJ; Pleiman, CM; Speelmon, EC; Tang, MM | 1 |
| Dong, YN; Fang, ZY; Hao, GX; Hou, SS; Huang, X; Li, X; Shi, HY; Tang, BH; Van Den Anker, J; Wu, YE; Yao, BF; Yu, YH; Zhao, W; Zheng, Y | 1 |
| García Carretero, R; Lopez-Lomba, M; Rodriguez-Maya, B; Vazquez-Gomez, O | 1 |
| Mueller, BA; Shaw, AR | 1 |
| Goodlet, KJ; Nailor, MD; Nicolau, DP | 1 |
| Kollef, MH; Micek, ST; Vazquez Guillamet, MC; Vazquez, R | 1 |
| Deresinski, S; Watkins, RR | 1 |
| Cipelli, R; Dangoor, A; Hodgson, M; Lester, JF; Naik, J; Newsom-Davis, T; Patel, A; Shah, R; Summerhayes, M; Talbot, D; Talbot, T | 1 |
| Hatti, M; Odenholt, I; Resman, F; Solomonidi, N; Tham, J | 1 |
| Colby, J; Fissell, WH; Groszek, JJ; Patel, P; Seegmiller, A; Shotwell, M; Verhoven, SM; Verstraete, A | 1 |
| Adam, T; Bachmann, F; Budde, K; Friedersdorff, F; Liefeldt, L; Slowinski, T; Waiser, J | 1 |
| Bernard, S; Lee, K; Pakyz, A; Stevens, M; Vaughan, D | 1 |
| Al Khalloufi, K; Endailalu, YW; Michael, M; Nabhani, H; Sealy, P | 1 |
| Docobo-Pérez, F; Domínguez-Herrera, J; Egea, P; López-Cerero, L; López-Rojas, R; Pachón, J; Pascual, A; Rodríguez-Baño, J | 1 |
| Falagas, ME; Ikawa, K; Tansarli, GS; Vardakas, KZ | 1 |
| Gupta, N; Rodrigues, C; Shetty, A; Soman, R | 1 |
| Ben Khalifa, S; Daiki, M; Fekih Hassen, A | 1 |
| Boots, RJ; Jarrett, P; Kirkpatrick, CM; Lipman, J; Roberts, JA; Varghese, JM | 1 |
| Doi, Y; Qureshi, ZA | 1 |
| Jain, N; Tewari, VV | 1 |
| Ahuja, T; Chen, D; Chen, XJ; Cutro, SR; Dubrovskaya, Y; Holzman, R; Mehta, SA; Papadopoulos, J; Phillips, MS; Scipione, MR | 1 |
| Badawi, C; Elhalwagy, H; Kumar, S; O'Kane, M | 1 |
| Bhat Y, R; Lewis, LE; Patra, S; Purakayastha, J; Sivaramaraju, VV | 1 |
| Garg, A; Goel, A; Nangia, S; Randhawa, VS; Saili, A; Sharma, S | 1 |
| Coleman, K; Girard, AM; Lavallade, L; Levasseur, P; Miossec, C; Pace, J | 1 |
| Antonucci, E; Beumier, M; Cristallini, S; de Backer, D; Donadello, K; Jacobs, F; Roberts, JA; Rondelet, B; Scolletta, S; Taccone, FS; Vincent, JL | 1 |
| Baek, JY; Sohn, KM | 1 |
| Araya, I; Contreras, S; Fasce, G; Hurtado, V; Núñez, E; Opazo, JL; Quiñones, LA; Saez, E | 1 |
| Jamal, JA; Lipman, J; Mat-Nor, MB; Mohamad-Nor, FS; Roberts, DM; Roberts, JA; Udy, AA; Wallis, SC | 1 |
| Cotton, F; Creteur, J; Gustot, T; Hites, M; Jacobs, F; Lheureux, O; Surin, R; Taccone, FS; Trepo, E; Vincent, JL; Wolff, F | 1 |
| El-Ibiary, S; Gorlitsky, B | 1 |
| Beardsley, J; Johnson, J; Liu, P; Luther, V; Ohl, C; Williamson, J | 1 |
| Nicholaus, P; Pallangyo, P | 1 |
| Deis, AS; Simpson, SQ; Whiles, BB | 1 |
| Cetinkaya, RA; Coşkun, O; Eyigün, CP; Görenek, L; Ide, T; Kiliç, S; Senses, Z | 1 |
| Dalley, AJ; Lipman, J; Roberts, JA; Roberts, MS; Robertson, TA | 1 |
| Dalley, AJ; Kirkpatrick, CM; Lipman, J; Roberts, JA; Roberts, MS | 1 |
| Doherty, JA; Khan, J; Kollef, MH; Micek, ST; Pervez, M; Reichley, RM; Welch, EC | 1 |
| De Backer, D; Delattre, I; Dugernier, T; Jacobs, F; Laterre, PF; Layeux, B; Spapen, H; Taccone, FS; Vincent, JL; Wallemacq, P; Wittebole, X | 1 |
| Subaalaxmi, MV | 1 |
| Bansal, D; Gautam, V; Marwaha, N; Marwaha, RK; Oberoi, S; Sharma, RR | 1 |
| Adam, HJ; DeCorby, M; Hoban, DJ; Karlowsky, JA; Rennie, R; Zhanel, GG | 1 |
| Braun, L; Fairchok, M; Flanagan, R; Mahlen, S; Sainato, R | 1 |
| Delattre, IK; Jacobs, F; Jacqmin, P; Laterre, PF; Musuamba, FT; Taccone, FS; Verbeeck, RK; Wallemacq, P | 1 |
| Bosch, J; Guiral, E; Soto, SM; Vila, J | 1 |
| Baird, AD; Floyd, MS; Macwilliam, JL; Mistry, R | 1 |
| Bond, CM; Bullard, MJ; Djogovic, D; Meurer, DP; Rowe, BH; Villa-Roel, C | 1 |
| Beumier, M; Cotton, F; De Backer, D; Hites, M; Jacobs, F; Lorent, S; Roisin, S; Seyler, L; Surin, R; Taccone, FS; Vincent, JL; Wolff, F | 1 |
| Chai, LY; Chee, YL; Chng, WJ; Ding, Y; Hsu, LY; Jin, J; Lee, YM; Poon, LM; Tan, LK | 1 |
| Bloom, BT; Chong, E; Delmore, P; Forur, L; Gordon, P; Reynolds, J; Shaw, J; Uner, H | 1 |
| Hoppe, UC; Kochanek, M; Larbig, R; Lehman, C; Michels, G; Reda, S; Rottländer, D | 1 |
| Chua, A; Jimenez, VE; Tortora, G; Younus, F | 1 |
| Deng, S; Han, C; Li, X; Liao, Z; Wang, W; Xu, W | 1 |
| Dittrich, P; Maier, A; Matzi, V; Nuhsbaumer, S; Pinter, H; Pinter, J; Smolle, J; Smolle-Jüttner, FM; Tomaselli, F; Woltsche, M | 1 |
| Cirioni, O; D'Amato, G; Ghiselli, R; Giacometti, A; Kamysz, W; Lukasiak, J; Mocchegiani, F; Naldoski, P; Orlando, F; Saba, V; Scalise, G; Silvestri, C; Sisti, V | 1 |
| Hameed, S; Johnson, M; Lipman, M; Tariq, S; Tyrer, M | 1 |
| Erovic, BM; Georgopoulos, A; Joukhadar, C; Müller, M; Sauermann, R; Zeitlinger, MA | 1 |
| Marinella, MA | 1 |
| Flidel-Rimon, O; Friedman, S; Leibovitz, E; Shinwell, ES | 1 |
| Al-Ebous, AD; Al-Jahmi, M; Al-Zuriqat, AN; Hiasat, B; Sarayrah, M | 1 |
| Fazeli, MR; Gholami, K; Mojtahedzadeh, M; Najafi, A; Rafati, MR; Rouini, MR; Tavakoli, H | 1 |
| Akay, T; Ozkan, S | 1 |
| Harada, AS; Lau, W | 1 |
| Agarwal, N; Agarwal, S; Arya, SC; Solanki, BS | 1 |
| Apolônio, ACM; Carvalho, MAR; Coutinho, SC; Diniz, CG; Farias, LM; Martins, WA; Nicoli, JR; Santos, KVD | 1 |
| Del Zompo, M; Fanos, V; Martinelli, V; Mussap, M; Stronati, M; Testa, M | 1 |
| Chow, P; Godambe, S; Maulidi, H | 1 |
| Fennelly, JJ; Kelly, DA | 1 |
| Brückner, O; Hahn, H; Trautmann, M | 1 |
| Hewitt, WL; Murphy, W; Winston, DJ; Young, LS | 1 |
| Gorbach, SL; Simon, GL; Snydman, DR; Tally, FP | 1 |
| Mirrett, S; Reimer, LG; Reller, LB | 1 |
| Bodey, GP; Bolivar, R; Fainstein, V; Hay, M; Jadeja, L; Keating, M; McCredie, K | 1 |
| Douglas, GF; File, TM; Johnson, LA; Salstrom, SJ; Tan, JS | 1 |
| Böhler, J; Busse-Grawitz, A; Keller, E; Krumme, B; Reetze-Bonorden, P; Schollmeyer, P | 1 |
| Chandy, M; Ebenezer, S; Jesudason, MV; Lalitha, MK | 1 |
| Flemmer, M; Oldfield, EC | 1 |
| Gel'fand, BR; Gel'fand, EB; Lapshina, IIu; Topazova, EN | 1 |
| Klimonova, NV; Lobakov, AI; Nasonov, VN; Savitskaia, KI; Savov, AM | 1 |
| Kokontis, L; Malanga, CJ; Mauzy, S | 1 |
| Aoki, I; Kikuchi, M; Torii, Y; Toyama, K; Wakasugi, K | 1 |
| Bateman, JM; Masterton, RG; Rainford, DJ | 1 |
| Aberg, B; Anjou, E; Good, Z; Jalakas, K; Kühn, I; Ransjö, U; Siggelkow, I | 1 |
| al Sayer, H; Aladeen, T; Asfar, SK; Baraka, A; Juma, T; Ma'Rafie, A | 1 |
| Bialkowska-Hobrzanska, H; Gopaul, D; Hammerberg, O | 1 |
| Amadori, S; Martino, P; Micozzi, A; Pulsoni, A; Tirindelli, C; Venditti, M | 1 |
| Spencer, RC; Taylor, AK; Winfield, DA | 1 |
| Benjamin, S; Da Costa, F; Ellis, L; Gore, M; Jameson, B; Large, J; Milliken, S; Powles, R; Smith, CL; Talbot, D | 1 |
| Gamillscheg, A; Hauer, C; Lackner, H; Slavc, I; Urban, C | 1 |
| Melekos, MD | 1 |
| De Pauw, B; Donnelly, P; Nováková, I | 1 |
| Ackerman, BH; Cerra, FB; Shikuma, LR; Solem, LD; Strate, RG; Weaver, RH; Zaske, DE | 1 |
| Bartelink, AK; Rozenberg-Arska, M; van Jaarsveld, BC; van Kesteren, RG; van Kregten, E | 1 |
| Hammerberg, O; Kurnitzki, C; Rosenbloom, D; Watts, J | 1 |
| Adachi, M; Fujimori, I; Kobayashi, Y; Sekita, T; Suzuki, Y; Tomii, M | 1 |
| Allerberger, F; Ausserer, B; Fink, FM; Frischhut-Schiffer, EM; Guggenbichler, JP | 1 |
| Berg, PA; Dienes, HP; Dörner, O; Piper, C; von Egidy, H | 1 |
| Bergerat, JP; Duclos, B; Dufour, P; Herbrecht, R; Lang, JM; Langs, JC; Oberling, F | 1 |
| Arpi, M; Jørgensen, PE; Pedersen, HF | 1 |
| Ito, S; Mikami, R; Mikasa, K; Narita, N; Sawaki, M; Tsukaguchi, K | 1 |
| Huovinen, P; Huovinen, S; Jacoby, GA; Torniainen, K | 1 |
| Munro, R; Rawlinson, W; Sorrell, T | 1 |
| Gompertz, H; Hershman, M; Reilly, D; Sackier, J; Swift, R; Wood, C | 1 |
| Bartzokas, CA; Mackie, MJ; Purohit, S; Reilly, JT | 1 |
| Cox, CE | 1 |
| Fu, KP; Gregory, FJ; Hetzel, N; Hung, PP | 1 |
| Cobbs, CG; Pierce, MA; Wofford, JD | 1 |
| Calia, FM; Johnson, DE; Thompson, B | 1 |
| Catovsky, D; Cohen, J; Darrell, JH; Donnelly, JP; Galton, DA; Goldman, JM; Marcus, RE; Want, SV; Worsley, AM | 1 |
| Holloway, WJ | 1 |
4 review(s) available for piperacillin and Sepsis
| Article | Year |
|---|---|
Comparison of Duration and Empiric Antibiotic Choice of Post-Operative Treatment in Abdominal Sepsis.
Topics: Anti-Bacterial Agents; Carbapenems; Humans; Intraabdominal Infections; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sepsis | 2022 |
Antibiotic Dosing in Continuous Renal Replacement Therapy.
Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Computer Simulation; Critical Illness; Humans; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Monte Carlo Method; Penicillanic Acid; Piperacillin; Renal Replacement Therapy; Sepsis; Tazobactam; Thienamycins | 2017 |
Escherichia coli sequence type 131: epidemiology and challenges in treatment.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Cystitis; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; United States | 2014 |
Delftia lacustris septicemia in a pheochromocytoma patient: case report and literature review.
Topics: Adrenal Gland Neoplasms; Aged; Anti-Bacterial Agents; Bacteremia; Catheter-Related Infections; Delftia; DNA, Bacterial; DNA, Ribosomal; Gram-Negative Bacterial Infections; Humans; Male; Penicillanic Acid; Pheochromocytoma; Piperacillin; RNA, Ribosomal, 16S; Sepsis; Sequence Analysis, DNA; Tazobactam | 2015 |
28 trial(s) available for piperacillin and Sepsis
| Article | Year |
|---|---|
Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial.
Topics: Adult; Anti-Bacterial Agents; Drug Monitoring; Female; Humans; Multiple Organ Failure; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis | 2022 |
Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis (the EASI-SWITCH trial): study protocol for a randomised controlled trial.
Topics: Administration, Intravenous; Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ciprofloxacin; Cost-Benefit Analysis; Drug Administration Schedule; Equivalence Trials as Topic; Humans; Meropenem; Multicenter Studies as Topic; Neoplasms; Neutropenia; Piperacillin; Pragmatic Clinical Trials as Topic; Quality of Life; Sepsis; Tazobactam; Treatment Outcome | 2020 |
Monotherapy with amikacin or piperacillin-tazobactum empirically in neonates at risk for early-onset sepsis: a randomized controlled trial.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; India; Infant, Newborn; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Risk Factors; Sepsis; Treatment Outcome | 2014 |
Role of prophylactic antibiotics in neonates born through meconium-stained amniotic fluid (MSAF)--a randomized controlled trial.
Topics: Amikacin; Amniotic Fluid; Anti-Bacterial Agents; Antibiotic Prophylaxis; Double-Blind Method; Female; Humans; Infant, Newborn; Infusions, Intravenous; Male; Meconium; Meconium Aspiration Syndrome; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pregnancy; Prospective Studies; Sepsis | 2015 |
Pharmacokinetics of piperacillin in critically ill patients receiving continuous venovenous haemofiltration: A randomised controlled trial of continuous infusion versus intermittent bolus administration.
Topics: Administration, Intravenous; Adult; Aged; Anti-Bacterial Agents; Blood Chemical Analysis; Critical Illness; Female; Hemofiltration; Humans; Male; Metabolic Clearance Rate; Microbial Sensitivity Tests; Middle Aged; Piperacillin; Prospective Studies; Sepsis | 2015 |
Piperacillin penetration into tissue of critically ill patients with sepsis--bolus versus continuous administration?
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Critical Illness; Female; Humans; Male; Piperacillin; Prospective Studies; Sepsis; Tissue Distribution; Young Adult | 2009 |
Population pharmacokinetics of four β-lactams in critically ill septic patients comedicated with amikacin.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Amikacin; Anti-Bacterial Agents; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Critical Illness; Drug Monitoring; Female; Humans; Male; Meropenem; Metabolic Clearance Rate; Middle Aged; Models, Biological; Piperacillin; Sepsis; Thienamycins; Tissue Distribution; Treatment Outcome | 2012 |
[A multicenter clinical trial of piperacillin/tazobactam in burn infection].
Topics: Adult; Burns; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Penicillanic Acid; Piperacillin; Sepsis; Tazobactam; Treatment Outcome | 2002 |
Management of diabetic foot in a Jordanian hospital.
Topics: Amikacin; Amputation, Surgical; Anti-Bacterial Agents; Ceftazidime; Chemotherapy, Adjuvant; Debridement; Diabetic Foot; Drug Combinations; Drug Monitoring; Humans; Imipenem; Kidney Diseases; Length of Stay; Lincomycin; Metronidazole; Patient Selection; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Severity of Illness Index; Treatment Outcome; Wound Healing; Wound Infection | 2005 |
Clinical efficacy of continuous infusion of piperacillin compared with intermittent dosing in septic critically ill patients.
Topics: Adult; Aged; Anti-Bacterial Agents; APACHE; Critical Illness; Drug Administration Schedule; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Piperacillin; Sepsis; Severity of Illness Index; Treatment Outcome | 2006 |
Evaluation of piperacillin sodium in the treatment of infections in immune compromised patients.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Female; Humans; Immunologic Deficiency Syndromes; Infusions, Parenteral; Male; Middle Aged; Neoplasms; Penicillins; Piperacillin; Sepsis | 1982 |
Clinical trial of piperacillin with acquisition of resistance by Pseudomonas and clinical relapse.
Topics: Adolescent; Adult; Aged; Carbenicillin; Clinical Trials as Topic; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillin Resistance; Penicillins; Piperacillin; Pseudomonas; Pseudomonas Infections; Recurrence; Sepsis; Urinary Tract Infections | 1980 |
Timentin versus piperacillin or moxalactam in the therapy of acute bacterial infections.
Topics: Acute Disease; Aged; Anti-Bacterial Agents; Bacterial Infections; Clavulanic Acids; Drug Combinations; Female; Hallucinations; Humans; Male; Middle Aged; Moxalactam; Penicillins; Piperacillin; Sepsis; Ticarcillin | 1984 |
Prophylax or perish?
Topics: Antibiotic Prophylaxis; Cholangiopancreatography, Endoscopic Retrograde; Humans; Penicillins; Piperacillin; Sepsis | 1996 |
[Piperacillin/tazobactam in the treatment of abdominal sepsis in patients with peritonitis].
Topics: Abdominal Abscess; Adult; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis | 1997 |
[Use of piperacillin-tazobactam in abdominal surgery].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; beta-Lactamase Inhibitors; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Penicillanic Acid; Penicillins; Peritonitis; Piperacillin; Sepsis; Surgical Wound Infection; Tazobactam; Treatment Outcome | 1997 |
Teicoplanin in the treatment of gram-positive bacteraemia in neutropenic patients.
Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Child; Child, Preschool; Drug Therapy, Combination; Fever; Glycopeptides; Gram-Positive Bacteria; Humans; Middle Aged; Neutropenia; Piperacillin; Prospective Studies; Sepsis; Teicoplanin | 1990 |
A comparative efficacy and safety study of teicoplanin plus aztreonam versus gentamicin plus piperacillin in haematology oncology patients with clinically diagnosed septicaemia.
Topics: Adult; Anti-Bacterial Agents; Aztreonam; Bacteria; Drug Therapy, Combination; Female; Gentamicins; Glycopeptides; Humans; Leukemia; Male; Middle Aged; Neoplasms; Piperacillin; Prospective Studies; Sepsis; Teicoplanin | 1990 |
Teicoplanin compared to flucloxacillin for antibiotic treatment of neutropenic patients.
Topics: Anti-Bacterial Agents; Bacteria; Bone Marrow Transplantation; Drug Therapy, Combination; Fever; Floxacillin; Gentamicins; Glycopeptides; Humans; Leukemia; Multiple Myeloma; Neutropenia; Piperacillin; Sepsis; Teicoplanin; Time Factors | 1990 |
Efficacy of prophylactic antimicrobial regimens in preventing infectious complications after transrectal biopsy of the prostate.
Topics: Aged; Bacteriuria; Biopsy, Needle; Drug Therapy, Combination; Enema; Humans; Male; Piperacillin; Povidone-Iodine; Premedication; Prospective Studies; Prostate; Sepsis | 1990 |
Amikacin plus piperacillin versus ceftazidime as initial therapy in granulocytopenic patients with presumed bacteremia.
Topics: Adolescent; Adult; Agranulocytosis; Amikacin; Aspergillosis; Aspergillus fumigatus; Ceftazidime; Cell Count; Drug Therapy, Combination; Female; Fever; Humans; Male; Piperacillin; Sepsis | 1990 |
Randomized trial using piperacillin versus ampicillin and amikacin for treatment of premature neonates with risk factors for sepsis.
Topics: Amikacin; Ampicillin; Bacterial Infections; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infant, Newborn; Infant, Premature, Diseases; Piperacillin; Random Allocation; Risk Factors; Sepsis | 1989 |
A prospective comparative study of cefotetan with piperacillin for prophylaxis against infection in elective colorectal surgery.
Topics: Cefotetan; Clinical Trials as Topic; Colonic Diseases; Female; Humans; Male; Piperacillin; Prospective Studies; Random Allocation; Rectal Diseases; Sepsis; Surgical Wound Infection | 1987 |
A randomized trial of Timentin and tobramycin versus piperacillin and tobramycin in febrile neutropenic patients.
Topics: Adolescent; Adult; Aged; Bacteria; Bacterial Infections; Clavulanic Acids; Clinical Trials as Topic; Drug Combinations; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neutropenia; Penicillin Resistance; Penicillins; Piperacillin; Random Allocation; Sepsis; Ticarcillin; Tobramycin | 1986 |
Timentin versus piperacillin in the treatment of hospitalized patients with urinary tract infections.
Topics: Adult; Aged; Bacteria; Bacterial Infections; Clavulanic Acids; Cross Infection; Drug Combinations; Drug Evaluation; Female; Humans; Male; Middle Aged; Penicillin Resistance; Penicillins; Piperacillin; Sepsis; Ticarcillin; Urinary Tract Infections | 1986 |
Comparative trial of ticarcillin plus clavulanic acid and piperacillin in the treatment of acute bacterial infection.
Topics: Acute Disease; Adult; Aged; Bacterial Infections; Clavulanic Acid; Clavulanic Acids; Clinical Trials as Topic; Drug Combinations; Female; Humans; Male; Middle Aged; Penicillins; Piperacillin; Sepsis; Ticarcillin | 1985 |
Ceftazidime as first-line therapy for fever in acute leukaemia.
Topics: Adolescent; Adult; Bacterial Infections; Cefotaxime; Ceftazidime; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Male; Middle Aged; Netilmicin; Neutropenia; Penicillin Resistance; Piperacillin; Random Allocation; Sepsis | 1985 |
Treatment of infections in hospitalized patients with ticarcillin plus clavulanic acid. A comparative study.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cefoxitin; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Female; Gram-Negative Bacteria; Hospitalization; Humans; Male; Penicillins; Piperacillin; Respiratory Tract Infections; Sepsis; Ticarcillin; Tobramycin | 1985 |
99 other study(ies) available for piperacillin and Sepsis
| Article | Year |
|---|---|
Characterization of CSP-1, a novel extended-spectrum beta-lactamase produced by a clinical isolate of Capnocytophaga sputigena.
Topics: Amino Acid Sequence; Amoxicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Capnocytophaga; Cephalosporins; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Sepsis | 2010 |
Evaluation of ceftazidime and NXL104 in two murine models of infection due to KPC-producing Klebsiella pneumoniae.
Topics: Animals; Anti-Bacterial Agents; Azabicyclo Compounds; Ceftazidime; Disease Models, Animal; Female; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Sepsis | 2011 |
β-lactam dosing at the early phase of sepsis: Performance of a pragmatic protocol for target concentration achievement in a prospective cohort study.
Topics: Anti-Bacterial Agents; beta-Lactams; Critical Illness; Humans; Meropenem; Piperacillin; Prospective Studies; Sepsis | 2022 |
The concomitant use of vancomycin and piperacillin-tazobactam is associated with acute kidney injury (AKI) in extremely low birth weight infants (ELBW).
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Case-Control Studies; Drug Therapy, Combination; Female; Humans; Infant, Extremely Low Birth Weight; Infant, Newborn; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sepsis; Vancomycin | 2022 |
Concerns about study design and suggestion of additional analysis of therapeutic drug monitoring-guided piperacillin/tazobactam therapy for patients with sepsis.
Topics: Anti-Bacterial Agents; Drug Monitoring; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis | 2022 |
Evaluation of Intravenous Push Piperacillin-Tazobactam on Time to Antibiotic Administration in Emergency Department Patients with Sepsis.
Topics: Anti-Bacterial Agents; Emergency Service, Hospital; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sepsis | 2023 |
Concerns about study design and suggestion of additional analysis of therapeutic drug monitoring-guided piperacillin/tazobactam therapy for patients with sepsis. Author's reply.
Topics: Anti-Bacterial Agents; Drug Monitoring; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis | 2022 |
The TARGET trial as a plea for model-informed precision dosing of piperacillin/tazobactam in patients with sepsis.
Topics: Anti-Bacterial Agents; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis | 2022 |
Clinical and microbiological features of intratumor abscess with bloodstream infection caused by Plesiomonas shigelloides, Citrobacter freundii, Streptococcus mitis/oralis, Clostridium perfringens, and Candida albicans in a patient with cholangiocarcinoma
Topics: Abscess; Aged; Antifungal Agents; Bacteremia; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Candida albicans; Cholangiocarcinoma; Citrobacter freundii; Clostridium perfringens; Humans; Levofloxacin; Male; Piperacillin; Plesiomonas; RNA, Ribosomal, 16S; Sepsis; Soil; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Streptococcus mitis; Streptococcus oralis; Tazobactam | 2022 |
Accuracy of a precision dosing software program for predicting antibiotic concentrations in critically ill patients.
Topics: Anti-Bacterial Agents; Critical Illness; Drug Monitoring; Humans; Meropenem; Piperacillin; Sepsis; Software; Vancomycin | 2023 |
Association between emergency department sepsis order set design and delay to second dose piperacillin-tazobactam administration.
Topics: Adult; Anti-Bacterial Agents; Emergency Service, Hospital; Humans; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sepsis; Tazobactam | 2023 |
Piperacillin-Tazobactam Compared With Cefoxitin as Antimicrobial Prophylaxis for Pancreatoduodenectomy: A Randomized Clinical Trial.
Topics: Adult; Aged; Anti-Bacterial Agents; Cefoxitin; Humans; Male; Pancreatic Fistula; Pancreaticoduodenectomy; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Surgical Wound Infection | 2023 |
Microdialysis as a safe and feasible method to study target-site piperacillin-tazobactam disposition in septic piglets and children.
Topics: Animals; Anti-Bacterial Agents; Child; Humans; Microdialysis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Swine; Tazobactam | 2023 |
Cefepime vs Piperacillin-Tazobactam in Adults Hospitalized With Acute Infection: The ACORN Randomized Clinical Trial.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Cefepime; Coma; Delirium; Drug Therapy, Combination; Female; Humans; Kidney; Male; Middle Aged; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sepsis | 2023 |
Prevalence and antimicrobial susceptibility of enterotoxigenic extra-intestinal Bacteroides fragilis among 13-year collection of isolates in Kuwait.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Toxins; Bacteroides fragilis; Bacteroides Infections; Cefoxitin; Clindamycin; Drug Resistance, Bacterial; Feces; Female; Humans; Imipenem; Kuwait; Male; Meropenem; Metronidazole; Microbial Sensitivity Tests; Piperacillin; Prevalence; Prospective Studies; Respiratory Tract Infections; Sepsis; Tigecycline; Wound Infection | 2020 |
Impact of extracorporeal membrane oxygenation (ECMO) support on piperacillin exposure in septic patients: a case-control study.
Topics: Aged; Anti-Bacterial Agents; Case-Control Studies; Extracorporeal Membrane Oxygenation; France; Humans; Middle Aged; Piperacillin; Prospective Studies; Sepsis | 2021 |
A retrospective cohort study assessing acute kidney injury and renal recovery among septic patients empirically treated with vancomycin piperacillin-tazobactam versus vancomycin cefepime.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Cefepime; Drug Therapy, Combination; Female; Humans; Male; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sepsis; Vancomycin | 2022 |
Clinical utiliy of a model-based piperacillin dose in neonates with early-onset sepsis.
Topics: Anti-Bacterial Agents; Humans; Infant; Infant, Newborn; Microbial Sensitivity Tests; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Sepsis | 2022 |
Bacteraemia and liver abscess due to
Topics: Abdominal Pain; Anti-Bacterial Agents; Bacteremia; Ceftriaxone; Fusobacterium Infections; Fusobacterium necrophorum; Humans; Liver Abscess; Male; Metronidazole; Middle Aged; Nausea; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Treatment Outcome; Vomiting | 2017 |
Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Febrile Neutropenia; Humans; Iatrogenic Disease; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Practice Guidelines as Topic; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Tazobactam; Thienamycins; Tobramycin | 2017 |
Reply to MacFadden et al.
Topics: Bacteremia; Cefepime; Gram-Negative Bacteria; Humans; Meropenem; Piperacillin; Sepsis; Tazobactam | 2018 |
Increasing Evidence of the Nephrotoxicity of Piperacillin/Tazobactam and Vancomycin Combination Therapy-What Is the Clinician to Do?
Topics: Anti-Bacterial Agents; Combined Modality Therapy; Drug Therapy, Combination; Humans; Kidney; Kidney Diseases; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Vancomycin | 2017 |
The burden of neutropenic sepsis in patients with advanced non-small cell lung cancer treated with single-agent docetaxel: A retrospective study.
Topics: Aged; Anti-Bacterial Agents; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cost of Illness; Docetaxel; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Outcome Assessment, Health Care; Penicillanic Acid; Piperacillin; Retrospective Studies; Sepsis; Taxoids; Tazobactam | 2017 |
Considerable variation of trough β-lactam concentrations in older adults hospitalized with infection-a prospective observational study.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Bacterial Infections; beta-Lactams; Cefotaxime; Drug Monitoring; Female; Humans; Length of Stay; Male; Meropenem; Patient Readmission; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Sepsis; Sweden; Thienamycins | 2018 |
Therapeutic drug monitoring of piperacillin and tazobactam by RP-HPLC of residual blood specimens.
Topics: Blood Specimen Collection; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Drug Monitoring; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Tazobactam | 2018 |
Perioperative antibiotic prophylaxis in renal transplantation: a single-center comparison between two regimens and a brief survey among the Eurotransplant renal transplantation centers.
Topics: Adult; Aged; Ampicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefazolin; Escherichia coli Infections; Europe; Female; Floxacillin; Humans; Kidney Transplantation; Male; Middle Aged; Perioperative Care; Piperacillin; Postoperative Complications; Retrospective Studies; Sepsis; Sex Factors; Sulbactam; Surgical Wound Infection; Surveys and Questionnaires; Urinary Tract Infections | 2019 |
Adequacy of empiric gram-negative coverage for septic patients at an academic medical center.
Topics: Academic Medical Centers; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefepime; Cephalosporins; Female; Gram-Negative Bacteria; Humans; Levofloxacin; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sepsis; Shock, Septic; Virginia; Young Adult | 2019 |
Klebsiella ozaenae sepsis in a young healthy male.
Topics: Adult; Anti-Bacterial Agents; Humans; Klebsiella; Klebsiella Infections; Male; Microbial Sensitivity Tests; Piperacillin; Sepsis; Sinusitis; Treatment Outcome | 2012 |
Inoculum effect on the efficacies of amoxicillin-clavulanate, piperacillin-tazobactam, and imipenem against extended-spectrum β-lactamase (ESBL)-producing and non-ESBL-producing Escherichia coli in an experimental murine sepsis model.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; beta-Lactamases; Colony Count, Microbial; Escherichia coli; Escherichia coli Infections; Female; Imipenem; Injections, Intramuscular; Injections, Intraperitoneal; Intraabdominal Infections; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Treatment Outcome | 2013 |
Reply to Soman et al and Frippiat et al.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Female; Humans; Male; Penicillanic Acid; Piperacillin; Sepsis | 2013 |
Are prolonged/continuous infusions of β-lactams for all?
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Female; Humans; Male; Penicillanic Acid; Piperacillin; Sepsis | 2013 |
Epidemiological and bacteriological profiles in children with burns.
Topics: Anti-Bacterial Agents; Burns; Child; Child, Preschool; Cohort Studies; Cross Infection; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Gentamicins; Humans; Male; Oxacillin; Piperacillin; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Wound Infection | 2014 |
Pharmacokinetics of piperacillin and tazobactam in plasma and subcutaneous interstitial fluid in critically ill patients receiving continuous venovenous haemodiafiltration.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Critical Illness; Extracellular Fluid; Female; Half-Life; Hemofiltration; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Prospective Studies; Sepsis; Tazobactam | 2014 |
Extended-Infusion versus standard-infusion piperacillin-tazobactam for sepsis syndromes at a tertiary medical center.
Topics: Aged; Anti-Bacterial Agents; Cost-Benefit Analysis; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Length of Stay; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sepsis; Survival Analysis; Syndrome; Tertiary Healthcare | 2014 |
Unusual presentation of PRES in the postnatal period.
Topics: Adult; Anti-Bacterial Agents; Antihypertensive Agents; Critical Care; Diagnosis, Differential; Female; Fluid Therapy; Follow-Up Studies; Headache; Humans; Labetalol; Magnesium Sulfate; Magnetic Resonance Imaging; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Posterior Leukoencephalopathy Syndrome; Postpartum Period; Seizures; Sepsis; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Cerebral abscess due to Serratia marcescens.
Topics: Amikacin; Anti-Bacterial Agents; Brain Abscess; Drainage; Frontal Lobe; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Long Term Adverse Effects; Magnetic Resonance Imaging; Male; Neurosurgical Procedures; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Serratia marcescens; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Efficacy of a Ceftazidime-Avibactam combination in a murine model of Septicemia caused by Enterobacteriaceae species producing ampc or extended-spectrum β-lactamases.
Topics: Animals; Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Ceftazidime; Drug Combinations; Escherichia coli; Escherichia coli Infections; Klebsiella Infections; Klebsiella pneumoniae; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis | 2014 |
β-Lactam pharmacokinetics during extracorporeal membrane oxygenation therapy: A case-control study.
Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Case-Control Studies; Extracorporeal Membrane Oxygenation; Female; Humans; Male; Meropenem; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas Infections; Sepsis; Serum; Thienamycins; Treatment Outcome | 2015 |
A Non-inferiority Pilot Study Comparing the Clinical Efficacy and Safety of Generic Wide-spectrum Antibiotic Use in Septic Oncology Patients.
Topics: Administration, Intravenous; Anti-Bacterial Agents; Cefoperazone; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drugs, Generic; Female; Humans; Imipenem; Male; Middle Aged; Oncology Service, Hospital; Penicillanic Acid; Pilot Projects; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Retrospective Studies; Sepsis; Sulbactam; Treatment Outcome | 2015 |
Serum β-lactam concentrations in critically ill patients with cirrhosis: a matched case-control study.
Topics: Aged; Anti-Bacterial Agents; Belgium; Case-Control Studies; Chromatography, High Pressure Liquid; Critical Illness; Databases, Factual; Drug Monitoring; Female; Humans; Liver Cirrhosis; Logistic Models; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Thienamycins | 2016 |
A Common But Not so Typical Elevated Anion Gap.
Topics: Acetone; Acidosis; Adult; Anti-Bacterial Agents; Blood Glucose; Confusion; Diabetes Complications; Fever; Fluid Therapy; Humans; Leg Injuries; Male; Methicillin-Resistant Staphylococcus aureus; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Sodium Bicarbonate; Staphylococcal Infections; Vancomycin | 2016 |
Frequency of empiric antibiotic de-escalation in an acute care hospital with an established Antimicrobial Stewardship Program.
Topics: Acute Disease; Aged; Anti-Bacterial Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Hospital Mortality; Humans; Length of Stay; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Retrospective Studies; Sepsis; Vancomycin | 2016 |
Disseminated tungiasis in a 78-year-old woman from Tanzania: a case report.
Topics: Aged; Animals; Anti-Bacterial Agents; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Ectoparasitic Infestations; Extremities; Female; Ferrous Compounds; Folic Acid; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Poverty Areas; Quality of Life; Sepsis; Severity of Illness Index; Tanzania; Tetanus Toxoid; Tolvaptan; Treatment Outcome; Tunga; Tungiasis; Vitamins | 2016 |
Increased Time to Initial Antimicrobial Administration Is Associated With Progression to Septic Shock in Severe Sepsis Patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Ceftriaxone; Comorbidity; Disease Progression; Female; Hospital Mortality; Humans; Length of Stay; Levofloxacin; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sepsis; Sex Factors; Shock, Septic; Time Factors; Time-to-Treatment; Vasoconstrictor Agents | 2017 |
The effect of methylprednisolone on treatment in rats with induced sepsis.
Topics: Animals; Disease Models, Animal; Methylprednisolone; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Rats; Rats, Sprague-Dawley; Sepsis | 2009 |
First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Critical Illness; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Piperacillin; Plasma; Sepsis; Young Adult | 2010 |
Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to Gram-negative bacteria: a retrospective analysis.
Topics: Acinetobacter Infections; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cefepime; Cephalosporins; Cohort Studies; Drug Therapy, Combination; Escherichia coli Infections; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Sepsis; Shock, Septic | 2010 |
Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Chromatography, High Pressure Liquid; Drug Therapy, Combination; Female; Humans; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Prospective Studies; Sepsis; Shock, Septic; Tazobactam; Thienamycins | 2010 |
Septicemic melioidosis.
Topics: Humans; Male; Melioidosis; Penicillanic Acid; Piperacillin; Sepsis; Tazobactam; Time Factors; Treatment Outcome | 2010 |
Antithymocyte globulin-induced acute lung injury during transplantation for aplastic anemia.
Topics: Acute Lung Injury; Anemia, Aplastic; Animals; Anti-Bacterial Agents; Antilymphocyte Serum; Bacterial Infections; Bone Marrow Transplantation; Child; Cyclophosphamide; Horses; Humans; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Transplantation Conditioning; Vancomycin; Vidarabine | 2011 |
Prevalence of antimicrobial resistant pathogens from blood cultures from Canadian hospitals: results of the CANWARD 2007-2009 study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Blood; Canada; Candida; Carbapenems; Child; Child, Preschool; Drug Resistance, Bacterial; Drug Resistance, Fungal; Emergency Service, Hospital; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infant; Infant, Newborn; Intensive Care Units; Microbial Sensitivity Tests; Middle Aged; Outpatient Clinics, Hospital; Patients' Rooms; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Polymerase Chain Reaction; Prevalence; Sepsis | 2011 |
Severe human parechovirus sepsis beyond the neonatal period.
Topics: Anti-Bacterial Agents; Blood Coagulation Disorders; Ceftriaxone; Enterocolitis, Necrotizing; Enzyme Inhibitors; Fever; Heart Failure; Hepatitis; Humans; Infant; Male; Parechovirus; Penicillanic Acid; Picornaviridae Infections; Piperacillin; Respiratory Insufficiency; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral; Sepsis; Sequence Analysis, RNA; Tazobactam | 2011 |
Antimicrobial resistance of Escherichia coli strains causing neonatal sepsis between 1998 and 2008.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Bacterial; Escherichia coli; Gentamicins; Humans; Infant, Newborn; Microbial Sensitivity Tests; Piperacillin; Sepsis; Tobramycin | 2012 |
Piperacillin/tazobactam induced thrombocytopaenia--a delayed response.
Topics: Anti-Bacterial Agents; Diagnosis, Differential; Female; Follow-Up Studies; Humans; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Platelet Count; Sepsis; Thrombocytopenia; Time Factors | 2012 |
Pilot study comparing sepsis management with and without electronic clinical practice guidelines in an academic emergency department.
Topics: Aged; Anti-Bacterial Agents; Clinical Protocols; Disease Management; Emergency Service, Hospital; Female; Hospitals, Teaching; Humans; Internet; Male; Middle Aged; Penicillanic Acid; Pilot Projects; Piperacillin; Piperacillin, Tazobactam Drug Combination; Practice Guidelines as Topic; Sepsis; Shock, Septic; Treatment Outcome | 2013 |
Case-control study of drug monitoring of β-lactams in obese critically ill patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Case-Control Studies; Cefepime; Ceftazidime; Cephalosporins; Drug Monitoring; Enzyme Inhibitors; Female; Humans; Male; Meropenem; Middle Aged; Obesity; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Renal Replacement Therapy; Sepsis; Shock, Septic; Tazobactam; Thienamycins; Young Adult | 2013 |
Risk factors for adverse outcomes and multidrug-resistant Gram-negative bacteraemia in haematology patients with febrile neutropenia in a Singaporean university hospital.
Topics: Academic Medical Centers; Adult; Bacteremia; Carbapenems; Ceftazidime; Drug Resistance, Multiple; Febrile Neutropenia; Female; Gram-Negative Bacteria; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Prevalence; Prospective Studies; Risk Factors; Sepsis; Singapore; Tazobactam; Treatment Outcome; Universities | 2012 |
Results of a two-center, before and after study of piperacillin-tazobactam versus ampicillin and gentamicin as empiric therapy for suspected sepsis at birth in neonates ≤ 1500 g.
Topics: Alkaline Phosphatase; Ampicillin; Apgar Score; Diaper Rash; Female; Gentamicins; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sepsis; Treatment Outcome | 2013 |
[Systemic hantavirus-infection in a comatose HIV patient].
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-HIV Agents; Coma; Critical Care; Diagnosis, Differential; Drug Therapy, Combination; Hemorrhagic Fever with Renal Syndrome; Hepatitis B, Chronic; Humans; Male; Penicillanic Acid; Piperacillin; Puumala virus; Respiratory Distress Syndrome; Sepsis; Tazobactam | 2013 |
Lemierre's disease caused by co-infection of Arcanobacterium haemolyticum and Fusobacterium necrophorum: a case report.
Topics: Actinomycetales; Actinomycetales Infections; Adult; Anti-Bacterial Agents; Drug Therapy, Combination; Fusobacterium Infections; Humans; Jugular Veins; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Thrombophlebitis; Vancomycin | 2002 |
Penetration of piperacillin and tazobactam into pneumonic human lung tissue measured by in vivo microdialysis.
Topics: Adult; Aged; Area Under Curve; Enzyme Inhibitors; Female; Humans; Lung; Male; Microdialysis; Middle Aged; Penicillanic Acid; Penicillins; Piperacillin; Pneumonia; Sepsis; Tazobactam | 2003 |
Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models.
Topics: Abdomen; Amino Acid Sequence; Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Cecum; Colony Count, Microbial; Endotoxins; Escherichia coli; Escherichia coli Infections; Injections, Intraperitoneal; Male; Microbial Sensitivity Tests; Penicillins; Peritonitis; Piperacillin; Rats; Rats, Wistar; Sepsis; Shock, Septic; Tumor Necrosis Factor-alpha | 2004 |
Pseudomonal sepsis with subcutaneous nodules in an HIV-infected individual with high CD4 counts.
Topics: Anti-Bacterial Agents; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4-Positive T-Lymphocytes; Gentamicins; Glucocorticoids; HIV Infections; Humans; Lymphocyte Count; Male; Middle Aged; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Pulmonary Disease, Chronic Obstructive; Respiration, Artificial; Sepsis; Skin Diseases; Tazobactam; Treatment Outcome | 2005 |
Plasma concentrations might lead to overestimation of target site activity of piperacillin in patients with sepsis.
Topics: Aged; Anti-Bacterial Agents; Humans; Microbial Sensitivity Tests; Middle Aged; Models, Biological; Organ Specificity; Piperacillin; Pseudomonas Infections; Sepsis; Staphylococcal Infections; Tissue Distribution | 2005 |
Group C streptococcal sepsis complicating Fournier gangrene.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Debridement; Diabetes Mellitus, Type 2; Drug Combinations; Fournier Gangrene; Humans; Male; Penicillanic Acid; Perineum; Piperacillin; Scrotum; Sepsis; Streptococcal Infections; Tazobactam | 2005 |
The use of piperacillin/tazobactam (in association with amikacin) in neonatal sepsis: efficacy and safety data.
Topics: Amikacin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infant, Newborn; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sepsis | 2006 |
Diaphragm paralysis in children after cardiac surgery.
Topics: Anti-Bacterial Agents; Cardiac Surgical Procedures; Cefazolin; Diaphragm; Female; Heart Defects, Congenital; Humans; Infant, Newborn; Ofloxacin; Paralysis; Phrenic Nerve; Piperacillin; Pneumonia; Postoperative Complications; Risk Factors; Sepsis | 2007 |
Successful treatment and limb salvage of mucor necrotizing fasciitis after kidney transplantation with posaconazole.
Topics: Alcaligenes; Amphotericin B; Amputation, Surgical; Antifungal Agents; Cefazolin; Combined Modality Therapy; Debridement; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Combinations; Drug Resistance, Multiple, Fungal; Escherichia coli Infections; Fatal Outcome; Fluconazole; Gangrene; Graft Rejection; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Leg; Leg Ulcer; Male; Middle Aged; Mucor; Mucormycosis; Penicillanic Acid; Phosphatidylcholines; Phosphatidylglycerols; Piperacillin; Postoperative Complications; Pyrimidines; Renal Dialysis; Reoperation; Sepsis; Skin Transplantation; Tazobactam; Triazoles; Voriconazole | 2007 |
Use of cefepime for the treatment of infections caused by extended spectrum: beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Hospitals, Urban; Humans; India; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Thienamycins | 2007 |
Comparative activity of ertapenem and piperacillin tazobactam in a murine systemic infection model with Bacteroides fragilis and Escherichia coli.
Topics: Animals; Anti-Bacterial Agents; Ascitic Fluid; Bacteroides fragilis; Bacteroides Infections; beta-Lactams; Blood; Colony Count, Microbial; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Mice; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis | 2007 |
Therapeutic drug monitoring of gentamicin in neonatal intensive care unit: experience in 68 newborns.
Topics: Anti-Bacterial Agents; Bacterial Infections; Birth Weight; Drug Monitoring; Drug Therapy, Combination; Female; Gentamicins; Gestational Age; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Male; Piperacillin; Sepsis | 2007 |
Suspected drug reaction with piperacillin/tazobactam, in a premature infant.
Topics: Anti-Bacterial Agents; Exanthema; Humans; Infant, Newborn; Infant, Premature; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Tazobactam | 2008 |
[Protective effect of Pseudomonas-specific immunoglobulin from the rabbit and of active immunization in experimental Pseudomonas sepsis in mice].
Topics: Animals; Antibodies, Bacterial; Cyclophosphamide; Immune Tolerance; Immunization; Immunization, Passive; Mice; Penicillins; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Sepsis | 1982 |
Piperacillin therapy for serious bacterial infections.
Topics: Adult; Aged; Bacterial Infections; Diarrhea; Drug Evaluation; Drug Hypersensitivity; Female; Humans; Immunosuppression Therapy; Kidney Failure, Chronic; Male; Microbial Sensitivity Tests; Middle Aged; Penicillin Resistance; Penicillins; Piperacillin; Respiratory Tract Infections; Sepsis; Urinary Tract Infections | 1980 |
Comparison of in vitro activity of moxalactam (LY127935) with cefazolin, amikacin, tobramycin, carbenicillin, piperacillin, and ticarcillin against 420 blood culture isolates.
Topics: Amikacin; Bacteria; Carbenicillin; Cefazolin; Cephalosporins; Cephamycins; Culture Media; Humans; Microbial Sensitivity Tests; Moxalactam; Penicillins; Piperacillin; Sepsis; Species Specificity; Ticarcillin; Tobramycin | 1980 |
Piperacillin plus vancomycin in the therapy of febrile episodes in cancer patients.
Topics: Bacterial Infections; Drug Combinations; Fever; Humans; Leukocyte Count; Neoplasms; Neutrophils; Piperacillin; Sepsis; Vancomycin | 1984 |
Single dose kinetics of piperacillin during continuous arteriovenous hemodialysis in intensive care patients.
Topics: Acute Kidney Injury; Adult; Aged; Critical Care; Female; Humans; Male; Middle Aged; Piperacillin; Renal Dialysis; Sepsis | 1995 |
In vitro evaluation of newer beta-lactam antibiotics against gram negative bacilli isolated from neutropenic patients.
Topics: Anti-Bacterial Agents; Azlocillin; Clavulanic Acid; Clavulanic Acids; Drug Evaluation; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Neutropenia; Piperacillin; Pseudomonas aeruginosa; Sepsis; Ticarcillin | 1994 |
Piperacillin-induced seizures.
Topics: Antimetabolites, Antineoplastic; Burkitt Lymphoma; Child; Humans; Male; Mercaptopurine; Methotrexate; Piperacillin; Pseudomonas Infections; Seizures; Sepsis; Staphylococcal Infections | 1997 |
[Clinical evaluation of sulbactam/cefoperazone for severe infections associated with hematological disorders].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefoperazone; Drug Synergism; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Male; Middle Aged; Opportunistic Infections; Piperacillin; Pneumonia; Sepsis; Sulbactam | 1992 |
Capnocytophaga canimorus infection and acute renal failure.
Topics: Acute Kidney Injury; Capnocytophaga; Gentamicins; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Multiple Organ Failure; Piperacillin; Sepsis | 1992 |
An outbreak of Klebsiella oxytoca septicemias associated with the use of invasive blood pressure monitoring equipment.
Topics: Adult; Aged; Blood Pressure Monitors; Disease Outbreaks; Drug Resistance, Microbial; Female; Humans; Klebsiella Infections; Male; Middle Aged; Piperacillin; Sepsis; Sweden | 1992 |
Necrotizing fasciitis.
Topics: Adult; Aged; Aged, 80 and over; Ampicillin; Combined Modality Therapy; Debridement; Drug Therapy, Combination; Fasciitis; Female; Humans; Male; Middle Aged; Necrosis; Piperacillin; Sepsis | 1991 |
Isolation of Agrobacterium radiobacter from a central venous catheter.
Topics: Amikacin; Catheterization, Central Venous; Catheters, Indwelling; Equipment Contamination; Female; Humans; Leukemia, Monocytic, Acute; Middle Aged; Piperacillin; Rhizobium; Sepsis | 1991 |
Imipenem-antibiotic monotherapy in juvenile cancer patients with neutropenia.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cefotaxime; Child; Child, Preschool; Cilastatin; Drug Therapy, Combination; Female; Humans; Imipenem; Infant; Male; Neoplasms; Neutropenia; Piperacillin; Retrospective Studies; Sepsis; Ticarcillin; Tobramycin | 1990 |
Effects of treatment and the metabolic response to injury on drug clearance: a prospective study with piperacillin.
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Half-Life; Humans; Inactivation, Metabolic; Male; Middle Aged; Piperacillin; Prospective Studies; Sepsis | 1990 |
[Fulminant sepsis caused by Streptococcus suis].
Topics: Adult; Animals; Critical Care; Humans; Male; Piperacillin; Sepsis; Serotyping; Streptococcal Infections; Streptococcus; Swine; Zoonoses | 1990 |
[Clinical studies on septicemia and infective endocarditis encountered between 1985-1986].
Topics: Adult; Aged; Aged, 80 and over; Cefmetazole; Cross Infection; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Humans; Male; Middle Aged; Piperacillin; Prognosis; Sepsis | 1989 |
Antibiotics for cholangitis.
Topics: Acute Disease; Ampicillin; Anti-Bacterial Agents; Bile; Cholangitis; Gram-Negative Bacteria; Humans; Mezlocillin; Piperacillin; Sepsis | 1989 |
[Empirical antimicrobial therapy of infection and fever episodes in children and adolescents with neutropenia caused by cytotoxic chemotherapy].
Topics: Adolescent; Agranulocytosis; Antineoplastic Agents; Cefamandole; Cefotaxime; Child; Child, Preschool; Drug Therapy, Combination; Female; Fever of Unknown Origin; Gentamicins; Humans; Infant; Infusion Pumps; Leukocyte Count; Male; Neoplasms; Neutropenia; Piperacillin; Sepsis | 1989 |
[Acute interstitial nephritis following piperacillin].
Topics: Aged; Drug Therapy, Combination; Female; Humans; Kidney; Kidney Function Tests; Nephritis, Interstitial; Piperacillin; Sepsis; Staphylococcal Infections; Staphylococcus epidermidis | 1989 |
[Treatment with a piperacillin and netilmicin combination of patients with agranulocytosis].
Topics: Adult; Aged; Agranulocytosis; Bacterial Infections; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Netilmicin; Piperacillin; Sepsis | 1988 |
In vitro studies of the synergism of piperacillin and netilmicin against blood culture isolates.
Topics: Bacteria; Drug Synergism; Enterobacter; Escherichia coli; Humans; Klebsiella; Microbial Sensitivity Tests; Netilmicin; Piperacillin; Pseudomonas aeruginosa; Sepsis; Staphylococcus aureus | 1986 |
[A case of chronic mucocutaneous candidiasis (CMCC) with repeated pulmonary abscess and sepsis].
Topics: Abscess; Adult; Candidiasis; Candidiasis, Chronic Mucocutaneous; Drug Therapy, Combination; Female; Humans; Hydrocortisone; Lung Diseases; Piperacillin; Recurrence; Sepsis; Streptococcal Infections; Streptococcus pyogenes | 1987 |
Incidence of inducible beta-lactamases in gram-negative septicemia isolates from twenty-nine European laboratories. European Study Group on Antibiotic Resistance.
Topics: Amdinocillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cephalosporins; Citrobacter; Enzyme Induction; Gram-Negative Bacteria; Humans; Lactams; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Sepsis | 1987 |
Evaluation of plasmid-encoded beta-lactamase resistance in Escherichia coli blood culture isolates.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Cefuroxime; Drug Resistance, Microbial; Enterobacteriaceae; Escherichia coli; Humans; Piperacillin; Plasmids; Pseudomonas; Sepsis | 1988 |
Bacteremia in neutropenic patients at a major teaching hospital--1981 to 1987.
Topics: Agranulocytosis; Amikacin; Australia; Cefotaxime; Drug Therapy, Combination; Gentamicins; Hospitals, Teaching; Humans; Neutropenia; Piperacillin; Sepsis; Ticarcillin | 1988 |
Synergistic activity of apalcillin and gentamicin in a combination therapy in experimental Pseudomonas bacteraemia of neutropenic mice.
Topics: Ampicillin; Animals; Drug Synergism; Drug Therapy, Combination; Female; Gentamicins; Mice; Microbial Sensitivity Tests; Naphthyridines; Neutropenia; Piperacillin; Pseudomonas Infections; Sepsis | 1986 |
Comparative activities of piperacillin, ceftazidime, and amikacin, alone and in all possible combinations, against experimental Pseudomonas aeruginosa infections in neutropenic rats.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Ceftazidime; Drug Therapy, Combination; Female; Neutropenia; Penicillin Resistance; Peritonitis; Piperacillin; Pseudomonas Infections; Rats; Rats, Inbred Strains; Sepsis | 1985 |